AAAAAA

   
Results: 1-10 |
Results: 10
Intraneoplastic polymer-based delivery of cyclophosphamide for intratumoral bioconversion by a replicating oncolytic viral vector
Authors: Ichikawa, T Petros, WP Ludeman, SM Fangmeier, J Hochberg, FH Colvin, OM Chiocca, EA
Citation: T. Ichikawa et al., Intraneoplastic polymer-based delivery of cyclophosphamide for intratumoral bioconversion by a replicating oncolytic viral vector, CANCER RES, 61(3), 2001, pp. 864-868
Pulmonary toxicity of induction chemotherapy prior to standard or high-dose chemotherapy with autologous hematopoietic support
Authors: Bhalla, KS Wilczynski, SW Abushamaa, AM Petros, WP McDonald, CS Loftis, JS Chao, NJ Vredenburgh, JJ Folz, RJ
Citation: Ks. Bhalla et al., Pulmonary toxicity of induction chemotherapy prior to standard or high-dose chemotherapy with autologous hematopoietic support, AM J R CRIT, 161(1), 2000, pp. 17-25
Pharmacokinetics and bioequivalence of a combined oral formulation of eniluracil, an inactivator of dihydropyrimidine dehydrogenase, and 5-fluorouracil in patients with advanced solid malignancies
Authors: Ochoa, L Hurwitz, HI Wilding, G Cohen, D Thomas, JP Schwartz, G Monroe, P Petros, WP Ertel, VP Hsieh, A Hoffman, C Drengler, R Magnum, S Rowinsky, EK
Citation: L. Ochoa et al., Pharmacokinetics and bioequivalence of a combined oral formulation of eniluracil, an inactivator of dihydropyrimidine dehydrogenase, and 5-fluorouracil in patients with advanced solid malignancies, ANN ONCOL, 11(10), 2000, pp. 1313-1322
Efficacy of liposomes and hyperthermia in a human tumor xenograft model: Importance of triggered drug release
Authors: Kong, G Anyarambhatla, G Petros, WP Braun, RD Colvin, OM Needham, D Dewhirst, MW
Citation: G. Kong et al., Efficacy of liposomes and hyperthermia in a human tumor xenograft model: Importance of triggered drug release, CANCER RES, 60(24), 2000, pp. 6950-6957
Metabolic jeopardy with high-dose cyclophosphamide? Not so fast
Authors: Petros, WP Colvin, OM
Citation: Wp. Petros et Om. Colvin, Metabolic jeopardy with high-dose cyclophosphamide? Not so fast, CLIN CANC R, 5(4), 1999, pp. 723-724
Phase I study of Doxil and vinorelbine in metastatic breast cancer
Authors: Burstein, HJ Ramirez, MJ Petros, WP Clarke, KD Warmuth, MA Marcom, PK Matulonis, UA Parker, LM Harris, LN Winer, EP
Citation: Hj. Burstein et al., Phase I study of Doxil and vinorelbine in metastatic breast cancer, ANN ONCOL, 10(9), 1999, pp. 1113-1116
Irinotecan therapy in adults with recurrent or progressive malignant glioma
Authors: Friedman, HS Petros, WP Friedman, AH Schaaf, LJ Kerby, T Lawyer, J Parry, M Houghton, PJ Lovell, S Rasheed, K Cloughsey, T Stewart, ES Colvin, OM Provenzale, JM McLendon, RE Bigner, DD Cokgor, I Haglund, M Rich, J Ashley, D Malczyn, J Elfring, GL Miller, LL
Citation: Hs. Friedman et al., Irinotecan therapy in adults with recurrent or progressive malignant glioma, J CL ONCOL, 17(5), 1999, pp. 1516-1525
Prognostic and predictive factors for patients with metastatic breast cancer undergoing aggressive induction therapy followed by high-dose chemotherapy with autologous stem-cell support
Authors: Rizzieri, DA Vredenburgh, JJ Jones, R Ross, M Shpall, EJ Hussein, A Broadwater, G Berry, D Petros, WP Gilbert, C Affronti, ML Coniglio, D Rubin, P Elkordy, M Long, GD Chao, NJ Peters, WP
Citation: Da. Rizzieri et al., Prognostic and predictive factors for patients with metastatic breast cancer undergoing aggressive induction therapy followed by high-dose chemotherapy with autologous stem-cell support, J CL ONCOL, 17(10), 1999, pp. 3064-3074
Two instruments to determine activated partial thromboplastin time: Implications for heparin monitoring
Authors: Taylor, CT Petros, WP Ortel, TL
Citation: Ct. Taylor et al., Two instruments to determine activated partial thromboplastin time: Implications for heparin monitoring, PHARMACOTHE, 19(4), 1999, pp. 383-387
Administration and pharmacokinetics of high-dose cyclophosphamide with hemodialysis support for allogeneic bone marrow transplantation in acute leukemia and end-stage renal disease
Authors: Perry, JJ Fleming, RA Rocco, MV Petros, WP Bleyer, AJ Radford, JE Powell, BL Hurd, DD
Citation: Jj. Perry et al., Administration and pharmacokinetics of high-dose cyclophosphamide with hemodialysis support for allogeneic bone marrow transplantation in acute leukemia and end-stage renal disease, BONE MAR TR, 23(8), 1999, pp. 839-842
Risultati: 1-10 |